A non-opioid drug for pain developed by UK biotech Levicept, with a new mechanism of action, has shown it can reduce pain associated with osteoarthritis in a phase 2 trial. Neurotrophin-3 (NT-3 ...

inhibitor – failed a phase 2 study in early symptomatic Alzheimer's. The experimental therapy didn't meet the primary endpoint of decreasing the change from baseline measured by the integrated ...

The biggest stories of the day delivered to your inbox.

Bayer is pressing ahead with a phase 3 trial of its oral Factor XIa inhibitor asundexian, a new anticoagulant, despite missing efficacy targets in two mid-stage studies. The OCEANIC trial ...

Armed with results from a phase 2 trial, Boehringer Ingelheim has said it will take its obesity drug candidate survodutide into a phase 3 programme later this year. The glucagon/GLP-1 receptor ...

Phase 2 results with once-weekly dosing of 20mg pelacarsen showed that 98% of patients achieved a reduction in Lp(a) levels that took them below the 50mg/dL threshold considered to be a risk ...

When Troll 2, the upcoming sequel to a hit Norwegian monster movie, becomes available with a Netflix subscription — like other movies set for an unspecified 2025 release date — remains unknown ...